Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Yield of training exchanges between Europe and Sub-Saharan Africa.
B-50Alternate Scoring of the Paced Auditory Serial Addition Test (PASAT): Evaluating Strings of Consecutive Correct Responses as Predictors of Cognitive Functioning in Patients with Multiple Sclerosis.
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Transcranial direct current stimulation ameliorates tactile sensory deficit in multiple sclerosis.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study.
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis.
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis.
Metabolite changes in radiologically isolated syndrome: More pathology than meets the eye?
Antibodies to potassium channels in multiple sclerosis.
Magnetic resonance imaging signatures of vascular pathology in multiple sclerosis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Pure sensory Guillain-Barré syndrome: A case report and review of the literature.
Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain.
Advanced MRI in multiple sclerosis: current status and future challenges.
The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis.
Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis.
Pages
« first
‹ previous
…
243
244
245
246
247
248
249
250
251
…
next ›
last »